- The Column Group participated in 5 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $168,800,000 (averaging $33,760,000 per round).
- Effector Therapeutics: Venture capital (Series C) ($38.6M)
- Peloton Therapeutics: Undisclosed funding ($22.2M)
- Surrozen: Venture capital (Series A) ($33M)
- Altitude Life Science Ventures
- Third Rock Ventures
- Osage University Partners
Want to see the complete list?